Universidad de Sevilla-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2019

  1. GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells

    Cell Death and Differentiation, Vol. 26, Núm. 10, pp. 1998-2014

2015

  1. Specific requirements for somatic cell therapy medicinal products and tissue engineered products

    Pharmaceuticals Policy and Law, Vol. 17, Núm. 1-2, pp. 271-277

  2. Specific requirements regarding module 5

    Pharmaceuticals Policy and Law, Vol. 17, Núm. 1-2, pp. 279-281